Chlorinated/VBN
dibenzo-p-dioxins/NNS
and/CC
dibenzofurans/NNS
and/CC
the/DT
human/JJ
immune/JJ
system/NN
./.
=====
1/LS
./.
Blood/NN
cell/NN
receptors/NNS
in/IN
volunteers/NNS
with/IN
moderately/RB
increased/VBN
body/NN
burdens/NNS
./.

Using/VBG
monoclonal/JJ
antibodies/NNS
(/(
mAbs/NNS
)/)
and/CC
flow/NN
cytometry/NN
,/,
we/PRP
studied/VBD
a/DT
variety/NN
of/IN
surface/NN
receptors/NNS
on/IN
lymphocyte/NN
subpopulations/NNS
of/IN
workers/NNS
with/IN
moderately/RB
increased/VBN
body/NN
burdens/NNS
of/IN
2,3,7,8-tetrachlorodibenzo-p-dioxin/NN
(/(
TCDD/NN
)/)
and/CC
of/IN
other/JJ
polychlorinated/VBN
dibenzo-p-dioxins/NNS
and/CC
dibenzofurans/NNS
(/(
PCDD/PCDF/NN
)/)
,/,
expressed/VBN
here/RB
as/IN
International-Toxicity/NN
Equivalencies/NN
(/(
I-TE/NN
)/)
./.
=====
The/DT
hypothesis/NN
to/TO
be/VB
tested/VBN
was/VBD
whether/IN
or/CC
not/RB
humans/NNS
exhibit/VBP
a/DT
similar/JJ
susceptibility/NN
to/TO
PCDDs/PCDFs/NNS
with/IN
respect/NN
to/TO
the/DT
surface/NN
receptors/NNS
found/VBN
previously/RB
to/TO
respond/VB
to/TO
small/JJ
doses/NNS
of/IN
2,3,7,8-tetrachlorodibenzo-p-dioxin/NN
(/(
TCDD/NN
)/)
in/IN
Callithrix/FW
jacchus/FW
./.
=====
These/DT
are/VBP
:/:
helper-inducer/JJ
(/(
memory/NN
)/)
T/NN
cells/NNS
(/(
CD4+CD45R0+CD45RA-CD29highCD11a+/JJ
)/)
,/,
CD20+/JJ
B/NN
cells/NNS
,/,
and/CC
cytotoxic/JJ
T/NN
cells/NNS
(/(
CD8+CD56+/CD57+/JJ
)/)
./.
=====
Furthermore/RB
,/,
68/CD
triple-labellings/NNS
with/IN
mAbs/NNS
were/VBD
performed/VBN
on/IN
the/DT
cells/NNS
of/IN
each/DT
volunteer/NN
to/TO
possibly/RB
generate/VB
further/JJ
hypotheses/NNS
./.
=====
It/PRP
was/VBD
evaluated/VBN
whether/IN
any/DT
of/IN
the/DT
variables/NNS
might/MD
be/VB
used/VBN
as/IN
a/DT
biomarker/NN
of/IN
effects/NNS
for/IN
this/DT
class/NN
of/IN
compounds/NNS
./.
=====
There/EX
were/VBD
two/CD
main/JJ
goals/NNS
:/:
(/(
1/LS
)/)
to/TO
evaluate/VB
whether/IN
workers/NNS
with/IN
a/DT
moderately/RB
increased/VBN
PCDD/PCDF-body/NN
burden/NN
[/(
25-140/CD
ppt/NN
TCDD/NN
or/CC
104-522/CD
ppt/NN
I-TE/NN
in/IN
blood/NN
fat/NN
]/)
exhibit/VBP
changes/NNS
in/IN
the/DT
surface/NN
receptors/NNS
of/IN
white/JJ
blood/NN
cells/NNS
,/,
as/IN
observed/VBN
in/IN
previous/JJ
studies/NNS
in/IN
non-human/JJ
primates/NNS
,/,
and/CC
(/(
2/LS
)/)
to/TO
clarify/VB
whether/IN
persons/NNS
at/IN
the/DT
upper/JJ
range/NN
[/(
10-23/CD
ppt/NN
TCDD/NN
or/CC
30-90/CD
ppt/NN
I-TE/NN
in/IN
blood/NN
fat/NN
]/)
of/IN
the/DT
body/NN
burden/NN
reference/NN
values/NNS
of/IN
a/DT
not/RB
particularly/RB
exposed/VBN
population/NN
show/VBP
detectable/JJ
deviations/NNS
in/IN
these/DT
immunological/JJ
variables/NNS
,/,
when/WRB
compared/VBN
with/IN
persons/NNS
at/IN
the/DT
lower/JJR
and/CC
medium/NN
range/NN
[/(
1-3/CD
ppt/NN
TCDD/NN
or/CC
9-29/CD
ppt/NN
I-TE/NN
]/)
of/IN
these/DT
body/NN
burden/NN
reference/NN
values/NNS
./.
=====
Regression/NN
analysis/NN
of/IN
our/PRP$
data/NNS
revealed/VBD
slight/JJ
trends/NNS
for/IN
some/DT
of/IN
the/DT
biomarkers/NNS
(/(
e.g./FW
CD45R0+/JJ
)/)
./.
=====
With/IN
one/CD
exception/NN
,/,
these/DT
were/VBD
all/DT
increases/NNS
./.
=====
None/NN
of/IN
the/DT
alterations/NNS
observed/VBN
are/VBP
of/IN
medical/JJ
relevance/NN
./.
=====
The/DT
slight/JJ
increase/NN
in/IN
the/DT
percentage/NN
of/IN
CD4+CD45R0+/JJ
cells/NNS
remained/VBD
significant/JJ
even/RB
after/IN
covariant/JJ
analysis/NN
taking/VBG
age-related/JJ
changes/NNS
into/IN
account/NN
./.
=====
Altogether/RB
,/,
the/DT
data/NNS
do/VBP
not/RB
provide/VB
any/DT
evidence/NN
to/TO
support/VB
an/DT
assumption/NN
that/IN
moderately/RB
increased/VBN
body/NN
burdens/NNS
of/IN
PCDDs/PCDFs/NNS
in/IN
adults/NNS
induce/VBP
decreases/NNS
in/IN
the/DT
cellular/JJ
components/NNS
of/IN
the/DT
human/JJ
immune/JJ
system/NN
./.
=====
Adult/JJ
humans/NNS
certainly/RB
are/VBP
less/RBR
susceptible/JJ
to/TO
this/DT
action/NN
of/IN
PCDDs/PCDFs/NNS
than/IN
adolescent/JJ
Callithrix/FW
jacchus/FW